James Beck on the Drug & Device Law Blog: Something Both Sides Should Agree On (re Class Actions)

September 21st, 2020|Categories: HB Emerging Law Notes, HB Tort Notes|Tags: , , , , , |

Senior Life Sciences Policy Analyst Reed Smith LLP Drug & Device Law Blog: Something Both Sides Should Agree On (re Class Actions) We’ll be very clear – as we have before:  We don’t like most class actions.  Indeed, if given our druthers, we would abolish Rule 23, as it applies to class actions for damages, altogether.  But that’s not in the offing anytime soon.  Today, we offer a class action decision that we think both sides, us on the defense and those on the plaintiffs side, can agree on, excluding only those responsible for the problem. In Pearson v. Target Corp., 968 F.3d 827 (7th Cir. 2020), the court came up with one possible solution to the class action “objector problem.” What’s that? Well, once a class action settles (as most do), all too often “objectors” come out of the woodwork.  While these [...]